Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaolei Wei, Yongqiang Wei, Fen Huang, Hui Jing, Muchen Xie, Xiaoxiao Hao & Ru Feng. (2015) Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 56:5, pages 1261-1265.
Read now
Read now
Chan Y. Cheah & John F. Seymour. (2014) Adding weight to a sinking ship: more reasons not to perform routine surveillance imaging in patients with diffuse large B-cell lymphoma in remission. Leukemia & Lymphoma 55:10, pages 2223-2225.
Read now
Read now
Articles from other publishers (15)
Helena J Janse van Rensburg, Pavlina Spiliopoulou & Lillian L Siu. (2022) Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents. The Oncologist 27:5, pages 352-362.
Crossref
Crossref
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, Michael von Bergwelt‐Baildon, Sophie Bernreiter, Antonio Cozzio, Hans T. Eich, Khaled Elsayad, Markus Follmann, Stephan Grabbe, Uwe Hillen, Wolfram Klapper, Claus‐Detlev Klemke, Carmen Loquai, Frank Meiss, Christina Mitteldorf, Ulrike Wehkamp, Dorothee Nashan, Jan P. Nicolay, Ilske Oschlies, Max Schlaak, René Stranzenbach, Rose Moritz, Christoph Stoll, Tibor Vag, Michael Weichenthal, Marion Wobser & Rudolf Stadler. (2022) S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:4, pages 537-555.
Crossref
Crossref
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, Michael von Bergwelt‐Baildon, Sophie Bernreiter, Antonio Cozzio, Hans
T. Eich, Khaled Elsayad, Markus Follmann, Stephan Grabbe, Uwe Hillen, Wolfram Klapper, Claus‐Detlev Klemke, Carmen Loquai, Frank Meiss, Christina Mitteldorf, Ulrike Wehkamp, Dorothee Nashan, Jan P. Nicolay, Ilske Oschlies, Max Schlaak, René Stranzenbach, Rose Moritz, Christoph Stoll, Tibor Vag, Michael Weichenthal, Marion Wobser & Rudolf Stadler. (2022) S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:4, pages 537-554.
Crossref
Crossref
Eliza A Hawkes, Zoe Loh, Ortis Estacio, Geoff Chong, Francis J Ha, Michael Gilbertson & Andrew Grigg. (2018) Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission. British Journal of Cancer 119:5, pages 546-550.
Crossref
Crossref
Beth Chasty, Michael Patterson, Louise J. Murray, Rod Johnson, Emma Thomas, Di Gilson, Cathy Burton & Robin J. D. Prestwich. (2018) Lack of effectiveness of routine clinic and blood test-based follow-up for diffuse large B cell lymphoma. British Journal of Haematology 182:1, pages 138-140.
Crossref
Crossref
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, Michael von Bergwelt-Baildon, Marc Beyer, Antonio Cozzio, Hans Theodor Eich, Markus Follmann, Stephan Grabbe, Uwe Hillen, Wolfram Klapper, Claus-Detlev Klemke, Cristina Lamos, Carmen Loquai, Frank Meiß, Dominik Mestel, Dorothee Nashan, Jan P. Nicolay, Ilske Oschlies, Max Schlaak, Christoph Stoll, Tibor Vag, Michael Weichenthal, Marion Wobser & Rudolf Stadler. (2018) S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86). JDDG: Journal der Deutschen Dermatologischen Gesellschaft 16:1, pages 112-123.
Crossref
Crossref
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, Michael von Bergwelt-Baildon, Marc Beyer, Antonio Cozzio, Hans Theodor Eich, Markus Follmann, Stephan Grabbe, Uwe Hillen, Wolfram Klapper, Claus-Detlev Klemke, Cristina Lamos, Carmen Loquai, Frank Meiß, Dominik Mestel, Dorothee Nashan, Jan P. Nicolay, Ilske Oschlies, Max Schlaak, Christoph Stoll, Tibor Vag, Michael Weichenthal, Marion Wobser & Rudolf Stadler. (2018) S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86). JDDG: Journal der Deutschen Dermatologischen Gesellschaft 16:1, pages 112-122.
Crossref
Crossref
Susan M. Hiniker & Richard T. Hoppe. (2017) Post-treatment surveillance imaging in lymphoma. Seminars in Oncology 44:5, pages 310-322.
Crossref
Crossref
Shu-Juan Zhou, Yong-Yong Ma, Yu Zhang, Sheng Luo, Li-Yuan Tang, Yi Chen, Lan Sun & Kang Yu. (2016) Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma. Annals of Hematology 96:2, pages 237-243.
Crossref
Crossref
Jonathon B Cohen, David M Kurtz, Ashley D Staton & Christopher R Flowers. (2015) Next-generation surveillance strategies for patients with lymphoma. Future Oncology 11:13, pages 1977-1991.
Crossref
Crossref
Susan M. Hiniker, Erqi L. Pollom, Michael S. Khodadoust, Margaret M. Kozak, Guofan Xu, Andrew Quon, Ranjana H. Advani & Richard T. Hoppe. (2015) Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology*Biology*Physics 92:1, pages 99-106.
Crossref
Crossref
Jonathon B. Cohen & Christopher R. Flowers. (2014) Optimal disease surveillance strategies in non-Hodgkin lymphoma. Hematology 2014:1, pages 481-487.
Crossref
Crossref
Esther Rabizadeh, Izhack Cherny, Ofir Wolach, Shany Sherman, Natalia Binkovski, Alon Peretz, Doron Lederfein & Aida Inbal. (2014) Increased Activity of Cell Membrane-Associated Prothrombinase, Fibrinogen-Like Protein 2, in Peripheral Blood Mononuclear Cells of B-Cell Lymphoma Patients. PLoS ONE 9:10, pages e109648.
Crossref
Crossref
Hardip SandhuHelen Maddock. (2013) Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury. Clinical Science 126:6, pages 377-400.
Crossref
Crossref
Junshik Hong, Hyun-Hwa Yoon, Hee Kyung Ahn, Sun Jin Sym, Jinny Park, Pil-Whan Park, Jeong Yeal Ahn, Sanghui Park, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2013) Prognostic Role of Serum Lactate Dehydrogenase Beyond Initial Diagnosis: A Retrospective Analysis of Patients with Diffuse Large B Cell Lymphoma. Acta Haematologica 130:4, pages 305-311.
Crossref
Crossref